未登录

S

Sanjita Paudel

korea institute of science and technology

H指数:8

被引数:229

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver (Adv. Mater. 7/2026)

脂滴抑制剂LDI通过破坏脂质积累并调控肝脏脂质谱，改善脂肪肝（Adv. Mater. 7/2026）

Advanced Materials

IF26.8

2026-02-020

OAAI

LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver

LDI，一种脂质滴抑制剂，破坏脂质积累并调节脂肪肝的肝脏脂质谱

Advanced Materials

IF26.8

2025-10-040

PRE

Characterization of formaldehyde-induced hepatotoxicity based on proteometabolomic analysis

基于蛋白质组代谢组学分析的甲醛诱导肝毒性的表征

Toxicology Letters

IF2.9

2025-09-020

PRE

Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1

组蛋白赖氨酸乙酰乙酰化作为HBO1调控的动态翻译后修饰的鉴定

ADVANCED SCIENCE

IF14.1

2023-06-298

OA

Novel Time-dependent Multi-omics Integration in Sepsis-associated Liver Dysfunction

GENOMICS PROTEOMICS & BIOINFORMATICS

IF7.9

2023-04-201

OAAI

Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer

IF5.5

2021-02-1018

OAAI

Discovery and Validation of a Novel Step Catalyzed by OsF3H in the Flavonoid Biosynthesis Pathway

IF3.5

2021-01-0614

OAAI

Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators

IF5.5

2019-09-165

OAAI

Himalayan honey loaded iron oxide nanoparticles: synthesis, characterization and study of antioxidant and antimicrobial activities

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2019-05-0137

OAAI

Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol

涉及Osthenol的人肝微粒体代谢的CYPs和UGTs的表征

IF5.5

2018-08-3010

OAAI

Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation

探索洛索洛芬在肝微粒体中的代谢: 细胞色素P450和UDP-葡萄糖醛酸基转移酶在其生物转化中的作用

IF5.5

2018-08-0213

OAAI